FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067182393> ?p ?o ?g. }

• W2067182393 endingPage "419" @default.
• W2067182393 startingPage "412" @default.
• W2067182393 abstract "We have investigated the effects of the low-toxic retinoid, all-trans retinoyl β-glucuronide (RAG) alone and in combination with the phenylacetate (PA) derivative 4-chloro-phenylacetate (4-CPA) on the human neuroblastoma cell line, LA-N-5. In vitro studies demonstrated that RAG and 4-CPA treatments alone showed differentiation-inducing activity on LA-N-5 cells, with 4-CPA found to be about three-fold more potent than the PA parent compound in inducing morphologic differentiation and growth inhibition. As previously reported for retinoic acid (RA) and PA, RAG and 4-CPA were significantly more effective in their antiproliferative effects on the cells than either agent alone. Pharmacologic studies of 4-CPA in mice demonstrated that blood plasma levels reached peak concentrations 4 h after bolus administration of the compound and showed slow clearance characteristics with an apparent half-life of 4–8 h. As opposed to PA, 4-CPA was found to be essentially odourless and readily consumed in drinking water, giving rise to steady-state blood plasma levels of 4-CPA in the near mM range. Continuous consumption of 4-CPA in this manner for up to 5 months demonstrated no apparent adverse effects on the mice. Long-term RAG- and/or 4-CPA-treatment of nude mice injected with LA-N-5 cells demonstrated that both compounds alone exhibit potent antitumour activity. Together, RAG plus 4-CPA was the most effective treatment for inhibiting established tumour growth. In contrast, 4-CPA alone was equally as effective as the combination for preventing tumour development. The potent in vivo antitumour effects of 4-CPA could not be accounted for by the known ability of PA compounds to induce expression of the RA nuclear receptor beta (RARβ) suppressor gene. Taken together, these findings demonstrate the possibility that RAG and/or 4-CPA may serve as effective, less-toxic alternatives to 13-cis RA, which is presently being utilised for nb therapy." @default.
• W2067182393 created "2016-06-24" @default.
• W2067182393 creator A5008899779 @default.
• W2067182393 creator A5011795469 @default.
• W2067182393 creator A5021012824 @default.
• W2067182393 creator A5024539701 @default.
• W2067182393 creator A5054172262 @default.
• W2067182393 creator A5085708802 @default.
• W2067182393 date "2003-07-01" @default.
• W2067182393 modified "2023-10-08" @default.
• W2067182393 title "In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells" @default.
• W2067182393 cites W105646620 @default.
• W2067182393 cites W1546224982 @default.
• W2067182393 cites W1547247128 @default.
• W2067182393 cites W160617378 @default.
• W2067182393 cites W1772646934 @default.
• W2067182393 cites W1833314019 @default.
• W2067182393 cites W1896807099 @default.
• W2067182393 cites W1966297487 @default.
• W2067182393 cites W1967920179 @default.
• W2067182393 cites W1976029914 @default.
• W2067182393 cites W1979087586 @default.
• W2067182393 cites W1987820038 @default.
• W2067182393 cites W1988791313 @default.
• W2067182393 cites W1992915212 @default.
• W2067182393 cites W1997484111 @default.
• W2067182393 cites W2001616502 @default.
• W2067182393 cites W2002019838 @default.
• W2067182393 cites W2006677785 @default.
• W2067182393 cites W2024384072 @default.
• W2067182393 cites W2031496356 @default.
• W2067182393 cites W2033720095 @default.
• W2067182393 cites W2040909018 @default.
• W2067182393 cites W2050021962 @default.
• W2067182393 cites W2055041961 @default.
• W2067182393 cites W2069522180 @default.
• W2067182393 cites W2074578409 @default.
• W2067182393 cites W2123389471 @default.
• W2067182393 cites W2140397231 @default.
• W2067182393 cites W2158407216 @default.
• W2067182393 cites W2164845334 @default.
• W2067182393 cites W2192990161 @default.
• W2067182393 cites W2315662514 @default.
• W2067182393 cites W2316183230 @default.
• W2067182393 cites W2327522594 @default.
• W2067182393 cites W2416258905 @default.
• W2067182393 cites W2479044294 @default.
• W2067182393 cites W39575425 @default.
• W2067182393 doi "https://doi.org/10.1038/sj.bjc.6601108" @default.
• W2067182393 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2394242" @default.
• W2067182393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12865937" @default.
• W2067182393 hasPublicationYear "2003" @default.
• W2067182393 type Work @default.
• W2067182393 sameAs 2067182393 @default.
• W2067182393 citedByCount "8" @default.
• W2067182393 countsByYear W20671823932018 @default.
• W2067182393 countsByYear W20671823932021 @default.
• W2067182393 crossrefType "journal-article" @default.
• W2067182393 hasAuthorship W2067182393A5008899779 @default.
• W2067182393 hasAuthorship W2067182393A5011795469 @default.
• W2067182393 hasAuthorship W2067182393A5021012824 @default.
• W2067182393 hasAuthorship W2067182393A5024539701 @default.
• W2067182393 hasAuthorship W2067182393A5054172262 @default.
• W2067182393 hasAuthorship W2067182393A5085708802 @default.
• W2067182393 hasBestOaLocation W20671823931 @default.
• W2067182393 hasConcept C126322002 @default.
• W2067182393 hasConcept C134018914 @default.
• W2067182393 hasConcept C150903083 @default.
• W2067182393 hasConcept C185592680 @default.
• W2067182393 hasConcept C202751555 @default.
• W2067182393 hasConcept C207001950 @default.
• W2067182393 hasConcept C2775954498 @default.
• W2067182393 hasConcept C2776715637 @default.
• W2067182393 hasConcept C2776897752 @default.
• W2067182393 hasConcept C2779707156 @default.
• W2067182393 hasConcept C2779963572 @default.
• W2067182393 hasConcept C2781121885 @default.
• W2067182393 hasConcept C54355233 @default.
• W2067182393 hasConcept C55493867 @default.
• W2067182393 hasConcept C71924100 @default.
• W2067182393 hasConcept C81885089 @default.
• W2067182393 hasConcept C86803240 @default.
• W2067182393 hasConcept C98274493 @default.
• W2067182393 hasConceptScore W2067182393C126322002 @default.
• W2067182393 hasConceptScore W2067182393C134018914 @default.
• W2067182393 hasConceptScore W2067182393C150903083 @default.
• W2067182393 hasConceptScore W2067182393C185592680 @default.
• W2067182393 hasConceptScore W2067182393C202751555 @default.
• W2067182393 hasConceptScore W2067182393C207001950 @default.
• W2067182393 hasConceptScore W2067182393C2775954498 @default.
• W2067182393 hasConceptScore W2067182393C2776715637 @default.
• W2067182393 hasConceptScore W2067182393C2776897752 @default.
• W2067182393 hasConceptScore W2067182393C2779707156 @default.
• W2067182393 hasConceptScore W2067182393C2779963572 @default.
• W2067182393 hasConceptScore W2067182393C2781121885 @default.
• W2067182393 hasConceptScore W2067182393C54355233 @default.
• W2067182393 hasConceptScore W2067182393C55493867 @default.
• W2067182393 hasConceptScore W2067182393C71924100 @default.

• next